Celentyx Ltd is a ‘boutique’ CRO providing bespoke drug discovery services focused on human immunology across a broad range of therapeutic areas including autoimmunity, inflammation, immuno-oncology, fibrosis and neuroinflammation.
Celentyx has a highly experienced scientific team that develops and provides assays using human primary cells at all stages of the drug discovery pipeline. Situated in close proximity to major hospitals and blood services (with established partnerships), assays can be performed at scale using blood and tissue from healthy volunteers and patients with defined disease including deep access to their clinical records.
Celentyx has well-established assay platforms in multi-colour flow-cytometry, Cytof, high-content imaging, multiplex supernatant analysis (Luminex), super-resolution microscopy as well as proteomic and molecular biology capability, enabling high-resolution analysis of the human immune system for target discovery, screening, candidate selection, mechanism of action, and biomarker studies.
Celentyx is based in the UK (Oxford and Birmingham) and in addition to internationally recognised scientists within the company, benefits from the world-leading expertise of neighbouring translational medicine departments at the Universities of Oxford and Birmingham.
Company Details
- Employees
- 13
- Founded
- -
- Address
- Birmingham Research Park, Vincent Drive,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- celentyx.com
- Keywords
- Immuno-Oncology, Inflammation, Autoimmunity.
- HQ
- Birmingham
Celentyx Ltd Questions
Celentyx Ltd's website is celentyx.com
Celentyx Ltd's LinkedIn profile is https://uk.linkedin.com/company/celentyx-ltd
Celentyx Ltd has
13 employees.
View email and phone details for 13
employees at Celentyx Ltd.
Celentyx Ltd's industry is
Biotechnology Research
Celentyx Ltd's top competitors are
Hairclone,
Quest,
Nonacus Clinical Services (Formerly Informed Genomics),
Exgen Dx,
Orbsen Therapeutics Limited,
Gifford Bioscience Limited,
Resilient Collective,
Microbesng,
Bastion Therapeutics,
Nonacus.
Celentyx Ltd's categories are Biotechnology Research
Celentyx Ltd's founding year is 2007
